Phosphoric Acid

SCHEMBL5789137

O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mn+2].[Mn+2].[Mn+2].[Mn+2].[Mn+2].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-]

nearest known ligand 0.31

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1A ADRA1B ADRA1D ADRB1 ADRB2 ADRB3 CYP11B1 DPP4 FGFR1 FGFR2 FGFR3 FGFR4 HRH1 JAK1 JAK2 JAK3 KCNA1 KCNA10 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 KCNB1 KCNB2 KCNC1 KCNC2 KCNC3 KCNC4 KCND1 KCND2 KCND3 KCNF1 KCNG1 KCNG2 KCNG3 KCNG4 KCNH1 KCNH2 KCNH3 KCNH4 KCNH5 KCNH6 KCNH7 KCNH8 KCNQ1 KCNQ2 KCNQ3 KCNQ4 KCNQ5 KCNS1 KCNS2 KCNS3 KCNV1 KCNV2 KDR KIT NA OPRD1 OPRK1 OPRM1 P PDGFRB PIK3CD SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SMO TYK2 pol rplA rplB rplC rplD rplE rplF rplJ rplK rplL rplM rplN rplO rplP rplQ rplR rplS rplT rplU rplV rplW rplX rplY rpmA rpmB rpmC rpmD rpmE rpmF rpmG rpmH rpmI rpmJ rpsA rpsB rpsC rpsD rpsE rpsF rpsG rpsH rpsI rpsJ rpsK rpsL rpsM rpsN rpsO rpsP rpsQ rpsR rpsS rpsT rpsU ykgM ykgO

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 1)

	gene	UniProt	supporting neighbours	confidence
▸	SLC34A1	Q06495	1/20	0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
Phosphoric Acid SCHEMBL5788366	0.96	SLC34A1 (0.33)	SLC34A1
Phosphoric Acid SCHEMBL5803702	0.92	SLC34A1 (0.31)	SLC34A1
Phosphoric Acid SCHEMBL5788867	0.91	SLC34A1 (0.36)	SLC34A1
Phosphoric Acid SCHEMBL5805665	0.88	—	—
Phosphoric Acid SCHEMBL25384384	0.87	—	—
Phosphoric Acid SCHEMBL447012	0.87	SLC34A1 (0.39)	SLC34A1
Phosphoric Acid SCHEMBL5790236	0.87	SLC34A1 (0.39)	SLC34A1
Phosphoric Acid SCHEMBL5790024	0.87	SLC34A1 (0.39)	SLC34A1
Phosphoric Acid SCHEMBL17417264	0.87	—	—
Phosphoric Acid SCHEMBL5789294	0.83	LMNA (0.33)	SLC34A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
WO-2001014257-A9	MICROBIOLOGICAL WATER FILTER	WATERVISIONS INT INC (US)	2006-07-13	—	—	WO	disclosed
US-6957743-B2	Fluid water is passed through a purification material composed of apatite and absorption media in a fixed binder matrix.	WATERVISIONS INTERNATIONAL, INC. (US)	2005-10-25	—	—	US	disclosed
US-20030015467-A1	Microbiological water filter	JOHNSTON ARTHUR W (US)	2003-01-23	—	—	US	disclosed
EP-1214273-A1	MICROBIOLOGICAL WATER FILTER	Watervisions International, Inc. (US)	2002-06-19	—	—	EP	disclosed
WO-2001014257-A1	MICROBIOLOGICAL WATER FILTER	WATERVISIONS INTERNATIONAL, INC. (US)	2001-03-01	—	—	WO	disclosed
US-6187192-B1	WATER CONTAINING BACTERIA AND/OR VIRUSES IS PASSED THROUGH A PURIFICATION MATERIAL COMPOSED OF APATITE AND ABSORPTION MEDIA IN A FIXED BINDER MATRIX	WATERVISIONS INTERNATIONAL, INC.	2001-02-13	—	—	US	disclosed
US-6180016-B1	MIXTURE OF APATITE IN BINDER	WATERVISIONS INTERNATIONAL, INC.	2001-01-30	—	—	US	disclosed